Search results for "Lung"

showing 10 items of 2389 documents

Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizu…

2017

Immune-checkpoint inhibitors represent the new standard of care in patients with advanced NSCLC who progressed after first-line treatment. This work aim to assess any difference in both efficacy and safety profiles among Nivolumab, Pembrolizumab and Atezolizumab in pre-treated NSCLC patients. Randomized clinical trials comparing immune-checkpoint inhibitor versus docetaxel in pre-treated patients with advanced NSCLC were included and direct comparison meta-analysis of selected trials have been performed. Subsequently the summary estimates of Nivolumab, Pembrolizumab and Atezolizumab emerging from the direct meta-analysis were selected to provide the pooled estimates of hazard ratio (HR) and…

atezolizumabCancer ResearchLung NeoplasmsAntineoplastic AgentsDocetaxelAntibodies Monoclonal HumanizedNSCLCClinical Trials Phase II as TopicCostimulatory and Inhibitory T-Cell ReceptorsCarcinoma Non-Small-Cell LungPDL1HumansRandomized Controlled Trials as TopicnivolumabIncidenceAntibodies MonoclonalPneumoniaSurvival AnalysisPD1Treatment OutcomeClinical Trials Phase III as TopicOncologyimmune-checkpointTaxoidsatezolizumab; immune-checkpoint; nivolumab; NSCLC; PD1; PDL1; pembrolizumab; Oncology; Cancer Researchpembrolizumab
researchProduct

Search for weakly decaying b -flavored pentaquarks

2018

Investigations of the existence of pentaquark states containing a single $b$ (anti)quark decaying weakly into four specific final states J/$\psi K^+\pi^- p$, J/$\psi K^- \pi^- p$, J/$\psi K^- \pi^+ p$, and $J/\psi \phi (1020) p$ are reported. The data sample corresponds to an integrated luminosity of 3.0/fb in 7 and 8 TeV pp collisions acquired with the LHCb detector. Signals are not observed and upper limits are set on the product of the production cross section times branching fraction with respect to that of the $\Lambda_b$.

baryon: exoticPhysics and Astronomy (miscellaneous)7000 GeV-cms8000 GeV-cms01 natural sciencesPhysics Particles & FieldsSettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - ExperimentLuminosityHigh Energy Physics - Experiment (hep-ex)Hadron-Hadron scattering (experiments)scattering [p p][PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]exotic [baryon]LHCb - Abteilung HintonpentaquarkPhysics8000 GeV-cmsPhysicsParticle physicsPentaquark3. Good healthchannel cross section: branching ratio: upper limitExotic baryonpentaquark --> J/psi(3100) K- pi+ pBranching fraction Hadron-Hadron scattering (experiments) QCDpentaquark --> J/psi(3100) K- pi- pCERN LHC Coll7000 GeV-cmsPhysical Sciencespentaquark --> J/psi(3100) Phi(1020) pBranching fractionLHCcolliding beams [p p]Particle Physics - ExperimentQuarkParticle physicsp p: scatteringFOS: Physical sciencesAstronomy & AstrophysicsHadronsNOmultiquark[ PHYS.HEXP ] Physics [physics]/High Energy Physics - Experiment [hep-ex]0103 physical sciencesddc:530010306 general physicsLarge Hadron Collider (France and Switzerland)Science & Technologybranching ratio: upper limit [channel cross section]hep-ex010308 nuclear & particles physicsBranching fractionpentaquark --> J/psi(3100) K+ pi- pParticles and FieldGran Col·lisionador d'HadronsBottom quarkQCDLHC-BHEPLHCbHigh Energy Physics::ExperimentFísica de partículesExperimentsp p: colliding beamsexperimental resultsPhysical Review D
researchProduct

Argumentationsmuster in belgisch-niederländischen Konsiliensammlungen des 16. Jahrhunderts. "Policy considerations" in der ius commune-tradition

2006

International audience

belgisch-niederländischen Konsiliensammlungen[SHS.DROIT]Humanities and Social Sciences/Law[SHS.DROIT] Humanities and Social Sciences/LawArgumentationsmuster[ SHS.DROIT ] Humanities and Social Sciences/LawComputingMilieux_MISCELLANEOUS16. Jahrhunderts
researchProduct

An impaired alveolar-capillary barrier in vitro : effect of proinflammatory cytokines and consequences on nanocarrier interaction.

2009

The alveolar region of the lung is an important target for drug and gene delivery approaches. Treatment with drugs is often necessary under pathophysiological conditions, in which there is acute inflammation of the target organ. Therefore, in vitro models of the alveolar-capillary barrier, which mimic inflammatory conditions in the alveolar region, would be useful to analyse and predict effects of novel drugs on healthy or inflamed tissues. The epithelial cell line H441 was cultivated with primary isolated human pulmonary microvascular endothelial cells (HPMECs) or the endothelial cell line ISO-HAS-1 on opposite sides of a permeable filter support under physiological and inflammatory condi…

bilayerPathologytight junctions[SDV.BIO]Life Sciences [q-bio]/Biotechnologymedicine.medical_treatment[SDV]Life Sciences [q-bio]02 engineering and technology[SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC]nanocarrier interactionBiochemistry[SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB]Electric ImpedancePolyethyleneimineBarrier function0303 health sciencesTight junctionArticlesTransfection021001 nanoscience & nanotechnologyImmunohistochemistryCell biologyEndothelial stem cellCytokine[SDV.TOX]Life Sciences [q-bio]/Toxicology0210 nano-technologyBiotechnologymedicine.medical_specialtyBiomedical EngineeringBiophysicsBioengineering[SDV.BC]Life Sciences [q-bio]/Cellular BiologyGene deliveryBiologyLung injuryModels BiologicalCell LineProinflammatory cytokineBiomaterialsInterferon-gamma03 medical and health sciencesmedicineHumanslung injury030304 developmental biologyAnalysis of VarianceTumor Necrosis Factor-alphaEndothelial CellsBiological TransportCoculture Techniquesalveolar-capillary barrierAlveolar Epithelial CellsNanoparticles
researchProduct

Role of P-Glycoprotein for Resistance of Tumors to Anticancer Drugs: From Bench to Bedside

2014

Success of cancer chemotherapy is limited by simultaneous resistance towards many anticancer drugs making clinical combination therapy protocols less efficient. P-glycoprotein represents an efflux pump of the ABC transporter family, which recognizes and extrudes anticancer drugs of diverse chemical classes and biochemical functions. The P-glycoprotein-mediated profile of cross-resistance has been termed multidrug resistance (MDR). In our investigations, we focused on MDR of in vivo tumor lines maintained in mice. The development of in vivo resistance towards anthracyclines (doxorubicin, daunorubicin) in L1210 and S180 ascites tumor lines was accompanied with decreased uptake and increased e…

biologybusiness.industryDaunorubicinCancerDrug resistancePharmacologymedicine.diseaseMultiple drug resistanceIn vivobiology.proteinMedicineDoxorubicinbusinessLung cancerP-glycoproteinmedicine.drug
researchProduct

IL-27 enhances the lymphocyte mediated innate resistance to primary hookworm infection in the lungs

2020

AbstractInterleukin-27 (IL-27) is a heterodimeric cytokine of the IL-12 family, formed by non-covalent association of the promiscuous EBI3 subunit and selective p28 subunit. IL-27 is produced by mononuclear phagocytes and unfolds pleiotropic immune-modulatory functions through high affinity ligation to IL-27 receptor alpha (IL-27RA). While IL-27 is known to contribute to immunity and to end inflammation following numerous types of infections, its relevance for host defense against multicellular parasites is still poorly defined. Here, we investigated the role of IL-27 during infection with the soil-transmitted hookworm, Nippostrongylus brasiliensis, in its early intrapulmonary life cycle. I…

biologymedicine.medical_treatmentLymphocyteEBI3InflammationLung injurybiology.organism_classificationMicrobiologyCytokinemedicine.anatomical_structuremedicineTumor necrosis factor alphaNippostrongylus brasiliensismedicine.symptomCD8
researchProduct

Update on biomarkers for the detection of lung cancer

2017

Patients at risk for lung cancer may have subclinical disease for years before presentation. The diagnosis of this disease is primarily based on symptoms, and detection often occurs after curative intervention is no longer possible. At present, no lung cancer early-detection biomarker is clinically available. This study reviews the most recent advances in early detection and molecular diagnostic biomarkers for the detection of lung cancer. This review includes an overview of the various biological specimens and matrices in which these biomarkers could be analyzed, as well as the diverse strategies and approaches for identifying new biomarkers that are currently being explored. Several novel…

business.industryEarly detectionReviewDiseaseBioinformaticsmedicine.diseaseOncologyResearch basedMedicineDiagnostic biomarkerBiomarker (medicine)Subclinical diseasebusinessLung cancerLung Cancer: Targets and Therapy
researchProduct

Computerunterstützte Diagnostik in der Thoraxradiologie - aktuelle Schwerpunkte und Techniken

2003

The proliferation of digital data sets and the increasing amount of images, e. g. through the use of multislice spiral CT or multiple follow-up examinations in the context of new therapies, are ideal prerequisites for computer-aided diagnosis (CAD) in chest radiology. Multiple studies have described the applications and advantages of computer assistance in performing different diagnostic tasks. More powerful computers will enable the introduction of these systems into the clinical routine and could provide an enormous increase in morphological and functional information. The commercial introduction of tools for detection and visualization of pulmonary nodules has already begun. This is one …

business.industryFeature extractionContext (language use)Image processingCADMachine learningcomputer.software_genreVisualizationMedicineRadiology Nuclear Medicine and imagingSegmentationArtificial intelligenceMedical diagnosisNuclear medicinebusinesscomputerLung cancer screeningRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Radiodiagnostik der Lunge

2000

Die radiologischen Schnittbildverfahren, insbesondere die CT, haben sich innerhalb kurzer Zeit einen herausragenden Stellenwert in der Diagnostik von Lungenerkrankungen erworben. Dies umfasst in erster Linie die morphologische Darstellung pathologischer Prozesse mit hoher raumlicher Auflosung. Moderne technische Entwicklungen und kombinierte Untersuchungsstrategien eroffnen neue Einsatzgebiete und auch funktionelle Aussagen, die nach einer aktuellen Standortbestimmung gemeinsam mit den nuklearmedizinischen Verfahren verlangen. Dazu gehort die Diagnostik der Lungenembolie mittels Spiral-CT-Angiographie und MR-Angiographie der Pulmonalarterien. Hier hat sich mittlerweile die CT als alternativ…

business.industryLung diseaseMedicineRadiology Nuclear Medicine and imagingbusinessNuclear medicineDer Radiologe
researchProduct

Pneumokokken und Pneumokokkenimpfstoffe

2001

business.industryLung diseasePediatrics Perinatology and Child HealthMiddle ear diseaseMedicineSurgerybusinessMicrobiologyMonatsschrift Kinderheilkunde
researchProduct